-
Modra Pharmaceuticals Presents Preliminary Data from Phase IIb Trial of ModraDoc006/r in Metastatic Prostate Cancer at 2021 ASCO GU Annual Meeting
12 February, 2021
-
ModraDoc006/Ritonavir Offers Promising Therapeutic Option for mCRPC
11 February, 2021
-
Modra Pharmaceuticals Announces First Patients Treated in Phase IIb Metastatic Prostate Cancer Trial
14 August, 2019